SECURITIES PURCHASE
AGREEMENT
This Securities
Purchase Agreement (this “ Agreement ”) is dated
as of May 28, 2009, between T3 Motion, Inc., a Delaware
corporation (the “ Company ”), and each
purchaser identified on the signature pages hereto (each, including
its successors and assigns, a “ Purchaser ” and
collectively, the “ Purchasers ”).
WHEREAS, subject
to the terms and conditions set forth in this Agreement and
pursuant to Section 4(2) of the Securities Act of 1933, as
amended (the “ Securities Act ”), and
Rule 506 promulgated thereunder, the Company desires to issue
and sell to each Purchaser, and each Purchaser, severally and not
jointly, desires to purchase from the Company, securities of the
Company as more fully described in this Agreement.
NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement,
and for other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the Company and each
Purchaser agree as follows:
1.1
Definitions . In addition to the terms defined elsewhere in
this Agreement: (a) capitalized terms that are not otherwise
defined herein have the meanings given to such terms in the
Debentures (as defined herein), and (b) the following terms
have the meanings set forth in this Section 1.1:
“
Acquiring Person ” shall have the meaning ascribed to
such term in Section 4.7.
“
Action ” shall have the meaning ascribed to such term
in Section 3.1(j).
“
Affiliate ” means any Person that, directly or
indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person, as such
terms are used in and construed under Rule 405 under the
Securities Act.
“ Board
of Directors ” means the board of directors of the
Company.
“
Business Day ” means any day except Saturday, Sunday,
any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are
authorized or required by law or other governmental action to
close.
“
Closing ” means the closing of the purchase and sale
of the Securities pursuant to Section 2.1.
“ Closing
Date ” means the Trading Day when all of the Transaction
Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i) the
Purchasers’ obligations to pay the Subscription Amount and
(ii) the Company’s obligations to deliver the Securities have
been satisfied or waived.
“ Closing
Statement ” means the Closing Statement in the form
attached hereto as Annex A .
“
Commission ” means the United States Securities and
Exchange Commission.
“ Common
Stock ” means the common stock of the Company, par value
$0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed
into.
“ Common
Stock Equivalents ” means any securities of the Company
or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation,
any debt, preferred stock, rights, options, warrants or other
instrument that is at any time convertible into or exercisable or
exchangeable for, or otherwise entitles the holder thereof to
receive, Common Stock.
“ Company
Counsel ” means Richardson & Patel LLP, with offices
located at 10900 Wilshire Boulevard, Suite 500, Los Angeles,
CA 90024.
“
Conversion Price ” shall have the meaning ascribed to
such term in the Debentures.
“
Debentures ” means the 10% Secured Convertible
Debentures due, subject to the terms therein, 12 months from
their date of issuance, issued by the Company to the Purchasers
hereunder, in the form of Exhibit A attached
hereto.
“
Disclosure Schedules ” shall have the meaning ascribed
to such term in Section 3.1.
“
Discussion Time ” shall have the meaning ascribed to
such term in Section 3.2(f).
“
Evaluation Date ” shall have the meaning ascribed to
such term in Section 3.1(r).
“
Exchange Act ” means the Securities Exchange Act of
1934, as amended, and the rules and regulations promulgated
thereunder.
“ Exempt
Issuance ” means the issuance of (a) shares of
Common Stock or options to employees, attorneys, consultants (but
if to consultants, not to exceed 500,000 in any 12 month period,
subject to adjustment for reverse and forward stock splits and the
like), officers or directors of the Company pursuant to any stock
or option plan duly adopted for such purpose, by a majority of the
non-employee members of the Board of Directors or a majority of the
members of a committee of non-employee directors established for
such purpose, (b) securities upon the exercise or exchange of
or conversion of any Securities issued hereunder and/or other
securities exercisable or exchangeable for or convertible into
shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended
since the date of this Agreement to increase the number of such
securities or to decrease the exercise, exchange or conversion
price of such securities and (c) securities issued pursuant
to
2
acquisitions or
strategic transactions approved by a majority of the disinterested
directors of the Company, provided that any such issuance shall
only be to a Person which is, itself or through its subsidiaries,
an operating company in a business synergistic with the business of
the Company and in which the Company receives benefits in addition
to the investment of funds, but shall not include a transaction in
which the Company is issuing securities primarily for the purpose
of raising capital or to an entity whose primary business is
investing in securities.
“ FWS
” means Feldman Weinstein & Smith LLP with offices
located at 420 Lexington Avenue, Suite 2620, New York, New
York 10170-0002; and on and after June 1, 2009, Weinstein
Smith LLP at the same address.
“
GAAP ” shall have the meaning ascribed to such term in
Section 3.1(h).
“
Indebtedness ” shall have the meaning ascribed to such
term in Section 3.1(aa).
“
Intellectual Property Rights ” shall have the meaning
ascribed to such term in Section 3.1(o).
“ Legend
Removal Date ” shall have the meaning ascribed to such
term in Section 4.1(c).
“
Liens ” means a lien, charge, security interest,
encumbrance, right of first refusal, preemptive right or other
restriction.
“
Material Adverse Effect ” shall have the meaning
assigned to such term in Section 3.1(b).
“
Material Permits ” shall have the meaning ascribed to
such term in Section 3.1(m).
“ Maximum
Rate ” shall have the meaning ascribed to such term in
Section 5.17.
“
Participation Maximum ” shall have the meaning
ascribed to such term in Section 4.12(a).
“
Person ” means an individual or corporation,
partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of
any kind.
“
Pre-Notice ” shall have the meaning ascribed to such
term in Section 4.12(b).
“ Pro
Rata Portion ” shall have the meaning ascribed to such
term in Section 4.12(e).
3
“
Proceeding ” means an action, claim, suit,
investigation or proceeding (including, without limitation, an
informal investigation or partial proceeding, such as a
deposition), whether commenced or threatened.
“ Public
Information Failure ” shall have the meaning ascribed to
such term in Section 4.3(b).
“ Public
Information Failure Payments ” shall have the meaning
ascribed to such term in Section 4.3(b).
“
Purchaser Party ” shall have the meaning ascribed to
such term in Section 4.10.
“
Required Approvals ” shall have the meaning ascribed
to such term in Section 3.1(e).
“
Required Minimum ” means, as of any date, the maximum
aggregate number of shares of Common Stock then issued or
potentially issuable in the future pursuant to the Transaction
Documents, including any Underlying Shares issuable upon exercise
in full of all Warrants or conversion in full of all Debentures
(including Underlying Shares issuable as payment of interest on the
Debentures), ignoring any conversion or exercise limits set forth
therein, and assuming that the Conversion Price is at all times on
and after the date of determination 75% of the then Conversion
Price on the Trading Day immediately prior to the date of
determination.
“
Rule 144 ” means Rule 144 promulgated by the
Commission pursuant to the Securities Act, as such Rule may be
amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same
effect as such Rule.
“ SEC
Reports ” shall have the meaning ascribed to such term in
Section 3.1(h).
“
Securities ” means the Debentures, the Warrants, the
Warrant Shares and the Underlying Shares.
“
Securities Act ” means the Securities Act of 1933, as
amended, and the rules and regulations promulgated
thereunder.
“
Security Agreement ” means the Security Agreement,
dated the date hereof, among the Company and the Purchasers, in the
form of Exhibit E attached hereto.
“
Security Documents ” shall mean the Security
Agreement, the Subsidiary Guarantees and any other documents and
filing required thereunder in order to grant the Purchasers a first
priority security interest in the assets of the Company and the
Subsidiaries as provided in the Security Agreement, including all
UCC-1 filing receipts.
“ Short
Sales ” means all “short sales” as defined in
Rule 200 of Regulation SHO under the Exchange Act (but
shall not be deemed to include the location and/or
4
reservation of
borrowable shares of Common Stock), nor shall Short Sale include
any short sale or hedge against any basket of securities traded on
any public market, whether or not such basket includes the Common
Stock.
“
Subscription Amount ” means, as to each Purchaser, the
aggregate amount to be paid for Debentures and Warrants purchased
hereunder as specified below such Purchaser’s name on the
signature page of this Agreement and next to the heading
“Subscription Amount,” in United States dollars and in
immediately available funds.
“
Subsequent Financing ” shall have the meaning ascribed
to such term in Section 4.12(a).
“
Subsequent Financing Notice ” shall have the meaning
ascribed to such term in Section 4.12(b).
“
Subsidiary ” means any subsidiary of the Company as
set forth on Schedule 3.1(a) and shall, where applicable,
also include any direct or indirect subsidiary of the Company
formed or acquired after the date hereof.
“
Subsidiary Guarantee ” means the Subsidiary Guarantee,
dated the date hereof, by each Subsidiary in favor of the
Purchasers, in the form of Exhibit F attached
hereto.
“ To the
knowledge of the Company ” means the actual knowledge of
the management of the Company.
“ Trading
Day ” means a day on which the principal Trading Market
is open for trading.
“ Trading
Market ” means the following markets or exchanges on
which the Common Stock is listed or quoted for trading on the date
in question: the American Stock Exchange, the Nasdaq Capital
Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange or the OTC Bulletin Board.
“
Transaction Documents ” means this Agreement, the
Debentures, the Warrants, the Security Agreement, the Subsidiary
Guarantee, the Escrow Agreement, the Lock-Up Agreement and all
exhibits and schedules thereto and hereto and any other documents
or agreements executed in connection with the transactions
contemplated hereunder.
“
Transfer Agent ” means Securities Transfer
Corporation, the current transfer agent of the Company, with a
mailing address of 2591 Dallas Parkway, Suite 102, Frisco,
Texas 75034 and a facsimile number of 469-633-0088, and any
successor transfer agent of the Company.
“
Underlying Shares ” means the shares of Common Stock
issued and issuable upon conversion of the Debentures and upon
exercise of the Warrants.
5
“
Variable Rate Transaction ” shall have the meaning
ascribed to such term in Section 4.13.
“
Vision ” means Vision Opportunity Master Fund,
Ltd.
“
VWAP ” means, for any date, the price determined by
the first of the following clauses that applies: (a) if the
Common Stock is then listed or quoted on a Trading Market, the
daily volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on the Trading Market on which
the Common Stock is then listed or quoted for trading as reported
by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)); (b) if the OTC
Bulletin Board is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding
date) on the OTC Bulletin Board; (c) if the Common Stock is
not then listed or quoted for trading on the OTC Bulletin Board and
if prices for the Common Stock are then reported in the “Pink
Sheets” published by Pink OTC Markets, Inc. (or a similar
organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so
reported; or (d) in all other cases, the fair market value of
a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest
of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the
Company.
“
Warrants ” means, collectively, the Series E
Common Stock purchase warrants delivered to the Purchasers at the
Closing in accordance with Section 2.2(a) hereof, which
Warrants shall be exercisable immediately and have a term of
exercise equal to 5 years, in the form of
Exhibit C attached hereto.
“ Warrant
Shares ” means the shares of Common Stock issuable upon
exercise of the Warrants.
ARTICLE II.
PURCHASE AND SALE
2.1 Closing
. On the Closing Date, upon the terms and subject to the conditions
set forth herein, substantially concurrent with the execution and
delivery of this Agreement by the parties hereto, the Company
agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of $600,000 in principal
amount of the Debentures. Each Purchaser shall deliver to the
Company via wire transfer or a certified check of immediately
available funds equal to its Subscription Amount and the Company
shall deliver to each Purchaser its respective Debenture and a
Warrant, as determined pursuant to Section 2.2(a), and the
Company and each Purchaser shall deliver the other items set forth
in Section 2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and
2.3, the Closing shall occur at the offices of FWS or such other
location as the parties shall mutually agree.
6
(a) On or prior to
the Closing Date, the Company shall deliver or cause to be
delivered to each Purchaser the following:
(i) this Agreement
duly executed by the Company;
(ii) a legal
opinion of Company Counsel, substantially in the form of
Exhibit D attached hereto;
(iii) a Debenture
with a principal amount equal to such Purchaser’s
Subscription Amount, registered in the name of such
Purchaser;
(iv) a Warrant
registered in the name of such Purchaser to purchase up to 300,000
shares of Common Stock per each $600,000 of such Purchaser’s
Subscription Amount (pro-rata for lesser amounts), with an exercise
price equal to $1.20, subject to adjustment therein; and
(v) the Security
Agreement, duly executed by the Company and each Subsidiary, along
with all of the Security Documents, including the Subsidiary
Guarantee, duly executed by the parties thereto..
(b) On or prior to
the Closing Date, each Purchaser shall deliver or cause to be
delivered to the Company the following:
(i) this Agreement
duly executed by such Purchaser;
(ii) such
Purchaser’s Subscription Amount by wire transfer to the
account as specified in writing by the Company; and
(iii) the Security
Agreement duly executed by such Purchaser.
(a) The
obligations of the Company hereunder in connection with the Closing
are subject to the following conditions being met:
(i) the accuracy
in all material respects on the Closing Date of the representations
and warranties of the Purchasers contained herein (unless as of a
specific date therein);
(ii) all
obligations, covenants and agreements of each Purchaser required to
be performed at or prior to the Closing Date shall have been
performed; and
(iii) the delivery
by each Purchaser of the items set forth in Section 2.2(b) of
this Agreement.
(b) The respective
obligations of the Purchasers hereunder in connection
7
with the
Closing are subject to the following conditions being
met:
(i) the accuracy
in all material respects when made and on the Closing Date of the
representations and warranties of the Company contained herein
(unless as of a specific date therein);
(ii) all
obligations, covenants and agreements of the Company required to be
performed at or prior to the Closing Date shall have been
performed;
(iii) the delivery
by the Company of the items set forth in Section 2.2(a) of
this Agreement;
(iv) there shall
have been no Material Adverse Effect with respect to the Company
since the date hereof;
(v) from the date
hereof to the Closing Date, trading in securities generally as
reported by Bloomberg L.P. shall not have been suspended or
limited, or minimum prices shall not have been established on
securities whose trades are reported by such service, or on any
Trading Market, nor shall a banking moratorium have been declared
either by the United States or New York State authorities nor shall
there have occurred any material outbreak or escalation of
hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any
financial market which, in each case, in the reasonable judgment of
each Purchaser, makes it impracticable or inadvisable to purchase
the Securities at the Closing.
ARTICLE III.
REPRESENTATIONS AND WARRANTIES
3.1
Representations and Warranties of the Company . Except as
set forth in the Disclosure Schedules, which Disclosure Schedules
shall be deemed a part hereof and shall qualify any representation
or otherwise made herein to the extent of the disclosure contained
in the corresponding section of the Disclosure Schedules, the
Company hereby makes the following representations and warranties
to each Purchaser:
(a)
Subsidiaries . All of the direct and indirect subsidiaries
of the Company are set forth on Schedule 3.1(a) . The
Company owns, directly or indirectly, all of the capital stock or
other equity interests of each Subsidiary free and clear of any
Liens, and all of the issued and outstanding shares of capital
stock of each Subsidiary are validly issued and are fully paid,
non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b)
Organization and Qualification . The Company and each of the
Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in
8
good standing
under the laws of the jurisdiction of its incorporation or
organization (as applicable), with the requisite power and
authority to own and use its properties and assets and to carry on
its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of
its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and
the Subsidiaries is duly qualified to conduct business and is in
good standing as a foreign corporation or other entity in each
jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except
where the failure to be so qualified or in good standing, as the
case may be, could not have or reasonably be expected to result in:
(i) a material adverse effect on the legality, validity or
enforceability of any Transaction Document, (ii) a material
adverse effect on the results of operations, assets, business,
prospects or condition (financial or otherwise) of the Company and
the Subsidiaries, taken as a whole, or (iii) a material
adverse effect on the Company’s ability to perform in any
material respect on a timely basis its obligations under any
Transaction Document (any of (i), (ii) or (iii), a “
Material Adverse Effect ”) and no Proceeding has been
instituted in any such jurisdiction revoking, limiting or
curtailing or seeking to revoke, limit or curtail such power and
authority or qualification.
(c)
Authorization; Enforcement . The Company has the requisite
corporate power and authority to enter into and to consummate the
transactions contemplated by each of the Transaction Documents and
otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of each of the Transaction Documents by
the Company and the consummation by it of the transactions
contemplated hereby and thereby have been duly authorized by all
necessary action on the part of the Company and no further action
is required by the Company, the Board of Directors or the
Company’s stockholders in connection therewith other than in
connection with the Required Approvals. Each Transaction Document
has been (or upon delivery will have been) duly executed by the
Company and, when delivered in accordance with the terms hereof and
thereof, will constitute the valid and binding obligation of the
Company enforceable against the Company in accordance with its
terms, except: (i) as limited by general equitable principles
and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of
creditors’ rights generally, (ii) as limited by laws
relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as
indemnification and contribution provisions may be limited by
applicable law.
(d) No
Conflicts . The execution, delivery and performance of the
Transaction Documents by the Company and the consummation by the
Company of the other transactions contemplated hereby and thereby
do not and will not: (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s
certificate or articles of incorporation, bylaws or other
organizational or charter documents, (ii) conflict with, or
constitute a default (or an event that with notice or lapse of time
or both would become a default) under, result in the creation of
any Lien upon any of the properties or assets of the Company or any
Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time
or both) of, any
9
agreement,
credit facility, debt or other instrument (evidencing a Company or
Subsidiary debt or otherwise) or other understanding to which the
Company or any Subsidiary is a party or by which any property or
asset of the Company or any Subsidiary is bound or affected, or
(iii) subject to the Required Approvals, conflict with or
result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is
subject (including federal and state securities laws and
regulations), or by which any property or asset of the Company or a
Subsidiary is bound or affected; except in the case of each of
clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect.
(e) Filings,
Consents and Approvals . The Company is not required to obtain
any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other
federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance
by the Company of the Transaction Documents, other than:
(i) the filings required pursuant to Section 4.6 of this
Agreement, (ii) application(s) to each applicable Trading
Market for the listing of the Securities for trading thereon in the
time and manner required thereby and (iii) the filing of
Form D with the Commission and such filings as are required to
be made under applicable state securities laws (collectively, the
“ Required Approvals ”).
(f) Issuance of
the Securities . The Securities are duly authorized and, when
issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction
Documents. The Underlying Shares, when issued in accordance with
the terms of the Transaction Documents, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed
by the Company other than restrictions on transfer provided for in
the Transaction Documents. The Company has reserved from its duly
authorized capital stock a number of shares of Common Stock for
issuance of the Underlying Shares at least equal to the Required
Minimum on the date hereof.
(g)
Capitalization . The capitalization of the Company is as set
forth on Schedule 3.1(g) , which
Schedule 3.1(g) shall also include the number of shares
of Common Stock owned beneficially, and of record, by Affiliates of
the Company as of the date hereof. The Company has not issued any
capital stock since its most recently filed periodic report under
the Exchange Act, other than pursuant to the exercise of employee
stock options under the Company’s stock option plans, the
issuance of shares of Common Stock to employees pursuant to the
Company’s employee stock purchase plans and pursuant to the
conversion and/or exercise of Common Stock Equivalents outstanding
as of the date of the most recently filed periodic report under the
Exchange Act. No Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate
in the transactions contemplated by the Transaction Documents.
Except as a result of the purchase and sale of the Securities,
there are no outstanding options, warrants, scrip rights to
subscribe to, calls or commitments of any character whatsoever
relating to, or securities, rights or obligations convertible into
or exercisable or
10
exchangeable
for, or giving any Person any right to subscribe for or acquire any
shares of Common Stock, or contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may
become bound to issue additional shares of Common Stock or Common
Stock Equivalents. The issuance and sale of the Securities will not
obligate the Company to issue shares of Common Stock or other
securities to any Person (other than the Purchasers) and will not
result in a right of any holder of Company securities to adjust the
exercise, conversion, exchange or reset price under any of such
securities. All of the outstanding shares of capital stock of the
Company are validly issued, fully paid and nonassessable, have been
issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any
preemptive rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any
stockholder, the Board of Directors or others is required for the
issuance and sale of the Securities. There are no stockholders
agreements, voting agreements or other similar agreements with
respect to the Company’s capital stock to which the Company
is a party or, to the knowledge of the Company, between or among
any of the Company’s stockholders.
(h) SEC
Reports; Financial Statements . The Company has filed all
reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the
Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the two years preceding the date hereof (or such shorter period
as the Company was required by law or regulation to file such
material) (the foregoing materials, including the exhibits thereto
and documents incorporated by reference therein, being collectively
referred to herein as the “ SEC Reports ”) on a
timely basis or has received a valid extension of such time of
filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective dates, the SEC
Reports complied in all material respects with the requirements of
the Securities Act and the Exchange Act, as applicable, and none of
the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading. The Company has never been an issuer subject
to Rule 144(i) under the Securities Act. The financial statements
of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in
accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods
involved (“ GAAP ”), except as may be otherwise
specified in such financial statements or the notes thereto and
except that unaudited financial statements may not contain all
footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of
operations and cash flows for the periods then ended, subject, in
the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.
(i) Material
Changes; Undisclosed Events, Liabilities or Developments .
Since the date of the latest audited financial statements included
within the SEC Reports,
11
except as
specifically disclosed in a subsequent SEC Report filed prior to
the date hereof: (i) there has been no event, occurrence or
development that has had or that could reasonably be expected to
result in a Material Adverse Effect, (ii) the Company has not
incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the
ordinary course of business consistent with past practice and (B)
liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or disclosed in filings made
with the Commission, (iii) the Company has not altered its
method of accounting, (iv) the Company has not declared or
made any dividend or distribution of cash or other property to its
stockholders or purchased, redeemed or made any agreements to
purchase or redeem any shares of its capital stock and (v) the
Company has not issued any equity securities to any officer,
director or Affiliate, except pursuant to existing Company stock
option plans. The Company does not have pending before the
Commission any request for confidential treatment of information.
Except for the issuance of the Securities contemplated by this
Agreement or as set forth on Schedule 3.1(i) , no
event, liability or development has occurred or exists with respect
to the Company or its Subsidiaries or their respective business,
properties, operations or financial condition, that would be
required to be disclosed by the Company under applicable securities
laws at the time this representation is made or deemed made that
has not been publicly disclosed at least 1 Trading Day prior to the
date that this representation is made.
(j)
Litigation . There is no action, suit, inquiry, notice of
violation, proceeding or investigation pending or, to the knowledge
of the Company, threatened against or affecting the Company, any
Subsidiary or any of their respective properties before or by any
court, arbitrator, governmental or administrative agency or
regulatory authority (federal, state, county, local or foreign)
(collectively, an “ Action ”) which (i)
adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the
Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material
Adverse Effect. Neither the Company nor any Subsidiary, nor any
director or officer thereof, is or has been the subject of any
Action involving a claim of violation of or liability under federal
or state securities laws or a claim of breach of fiduciary duty.
There has not been, and to the knowledge of the Company, there is
not pending or contemplated, any investigation by the Commission
involving the Company or any current or former director or officer
of the Company. The Commission has not issued any stop order or
other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange
Act or the Securities Act.
(k) Labor
Relations . No material labor dispute exists or, to the
knowledge of the Company, is imminent with respect to any of the
employees of the Company, which could reasonably be expected to
result in a Material Adverse Effect. None of the Company’s or
its Subsidiaries’ employees is a member of a union that
relates to such employee’s relationship with the Company or
such Subsidiary, and neither the Company nor any of its
Subsidiaries is a party to a collective bargaining agreement, and
the Company and its Subsidiaries believe that their relationships
with their employees are good. No executive officer, to the
knowledge of the Company, is, or is now expected to
12
be, in
violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or
non-competition agreement, or any other contract or agreement or
any restrictive covenant in favor of any third party, and the
continued employment of each such executive officer does not
subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its
Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and
employment practices, terms and conditions of employment and wages
and hours, except where the failure to be in compliance could not,
individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.
(l)
Compliance . Neither the Company nor any Subsidiary:
(i) is in default under or in violation of (and no event has
occurred that has not been waived that, with notice or lapse of
time or both, would result in a default by the Company or any
Subsidiary under), nor has the Company or any Subsidiary received
notice of a claim that it is in default under or that it is in
violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or
any of its properties is bound (whether or not such default or
violation has been waived), (ii) is in violation of any order
of any court, arbitrator or governmental body or (iii) is or
has been in violation of any statute, rule or regulation of any
governmental authority, including without limitation all foreign,
federal, state and local laws applicable to its business and all
such laws that affect the environment, except in each case as could
not have or reasonably be expected to result in a Material Adverse
Effect.
(m) Regulatory
Permits . The Company and the Subsidiaries possess all
certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary
to conduct their respective businesses as described in the SEC
Reports, except where the failure to possess such permits could not
reasonably be expected to result in a Material Adverse Effect
(“ Material Permits ”), and neither the Company
nor any Subsidiary has received any notice of proceedings relating
to the revocation or modification of any Material
Permit.
(n) Title to
Assets . The Company and the Subsidiaries have good and
marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by
them that is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens, except for
Liens as do not materially affect the value of such property and do
not materially interfere with the use made and proposed to be made
of such property by the Company and the Subsidiaries and Liens for
the payment of federal, state or other taxes, the payment of which
is neither delinquent nor subject to penalties. Any real property
and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases
with which the Company and the Subsidiaries are in
compliance.
(o) Patents and
Trademarks . The Company and the Subsidiaries have, or have
rights to use, all patents, patent applications, trademarks,
trademark applications, service
13
marks, trade
names, trade secrets, inventions, copyrights, licenses and other
intellectual property rights and similar rights as described in the
SEC Reports as necessary or material for use in connection with
their respective businesses and which the failure to so have could
have a Material Adverse Effect (collectively, the “
Intellectual Property Rights ”). Neither the Company
nor any Subsidiary has received a notice (written or otherwise)
that any of the Intellectual Property Rights used by the Company or
any Subsidiary violates or infringes upon the rights of any Person.
To the knowledge of the Company, all such Intellectual Property
Rights are enforceable and there is no existing infringement by
another Person of any of the Intellectual Property Rights. The
Company and its Subsidiaries have taken reasonable security
measures to protect the secrecy, confidentiality and value of all
of their intellectual properties, except where failure to do so
could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.
(p)
Insurance . The Company and the Subsidiaries are insured by
insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the
businesses in which the Company and the Subsidiaries are engaged,
including, but not limited to, directors and officers insurance
coverage at least equal to the aggregate Subscription Amount.
Neither the Company nor any Subsidiary has any reason to believe
that it will not be able to renew its existing insurance coverage
as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business
without a significant increase in cost.
(q)
Transactions With Affiliates and Employees . Except as set
forth in the SEC Reports, none of the officers or directors of the
Company and, to the knowledge of the Company, none of the employees
of the Company is presently a party to any transaction with the
Company or any Subsidiary (other than for services as employees,
officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by,
providing for rental of real or personal property to or from, or
otherwise requiring payments to or from any officer, director or
such employee or, to the knowledge of the Company, any entity in
which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee or partner, in each
case in excess of $120,000 other than for: (i) payment of
salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the
Company and (iii) other employee benefits, including stock
option agreements under any stock option plan of the
Company.
(r)
Sarbanes-Oxley; Internal Accounting Controls . The Company
is in material compliance with all provisions of the Sarbanes-Oxley
Act of 2002 which are applicable to it as of the Closing Date. The
Company and the Subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurance
that: (i) transactions are executed in accordance with
management’s general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of
financial statements in conformity with GAAP and to maintain asset
accountability, (iii) access to assets is permitted only in
accordance with management’s general or specific
14
authorization,
and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Company has
established disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and designed such disclosure controls and procedures to ensure that
information required to be disclosed by the Company in the reports
it files or submits under the Exchange Act is recorded, processed,
summarized and reported, within the time periods specified in the
Commission’s rules and forms. The Company’s certifying
officers have evaluated the effectiveness of the Company’s
disclosure controls and procedures as of the end of the period
covered by the Company’s most recently filed periodic report
under the Exchange Act (such date, the “ Evaluation
Date ”). The Company presented in its most recently filed
periodic report under the Exchange Act the conclusions of the
certifying officers about the effectiveness of the disclosure
controls and procedures based on their evaluations as of the
Evaluation Date. Since the Evaluation Date, there have been no
changes in the Company’s internal control over financial
reporting (as such term is defined in the Exchange Act) that has
materially affected, or is reasonably likely to materially affect,
the Company’s internal control over financial
reporting.
(s) Certain
Fees . No brokerage or finder’s fees or commissions are
or will be payable by the Company to any broker, financial advisor
or consultant, finder, placement agent, investment banker, bank or
other Person with respect to the transactions contemplated by the
Transaction Documents. The Purchasers shall have no obligation with
respect to any fees or with respect to any claims made by or on
behalf of other Persons for fees of a type contemplated in this
Section that may be due in connection with the transactions
contemplated by the Transaction Documents.
(t) Private
Placement . Assuming the accuracy of the Purchasers’
representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and
sale of the Securities by the Company to the Purchasers as
contemplated hereby. The issuance and sale of the Securities
hereunder does not contravene the rules and regulations of the
Trading Market.
(u) Investment
Company . The Company is not, and is not an Affiliate of, and
immediately after receipt of payment for the Securities, will not
be or be an Affiliate of, an “investment company”
within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner so that
it will not become subject to the Investment Company Act of 1940,
as amended.
(v)
Registration Rights . Other than each of the Purchasers, no
Person has any right to cause the Company to effect the
registration under the Securities Act of any securities of the
Company.
(w) Listing and
Maintenance Requirements . The Common Stock is registered
pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge
is likely to have the effect of, terminating the registration of
the Common Stock under the Exchange Act nor has the
Company
15
received any
notification that the Commission is contemplating terminating such
registration. The Company has not, in the 12 months preceding
the date hereof, received notice from the Over-the-Counter Bulletin
Board to the effect that the Company is not in compliance with the
listing or maintenance requirements of such Trading Market. The
Company is, and has no reason to believe that it will not in the
foreseeable future continue to be, in compliance with all such
listing and maintenance requirements.
(x) Application
of Takeover Protections . The Company and the Board of
Directors have taken all necessary action, if any, in order to
render inapplicable any control share acquisition, business
combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the
Company’s certificate of incorporation (or similar charter
documents) or the laws of its state of incorporation that is or
could become applicable to the Purchasers as a result of the
Purchasers and the Company fulfilling their obligations or
exercising their rights under the Transaction Documents, including
without limitation as a result of the Company’s issuance of
the Securities and the Purchasers’ ownership of the
Securities.
(y)
Disclosure . Except with respect to the material terms and
conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other
Person acting on its behalf has provided any of the Purchasers or
their agents or counsel with any information that it believes
constitutes or might constitute material, non-public information.
The Company understands and confirms that the Purchasers will rely
on the foregoing representation in effecting transactions in
securities of the Company. All disclosure furnished by or on behalf
of the Company to the Purchasers regarding the Company, its
business and the transactions contemplated hereby, including the
Disclosure Schedules to this Agreement, is true and correct and
does not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements
made therein, in light of the circumstances under which they were
made, not misleading. The press releases disseminated by the
Company during the twelve months preceding the date of this
Agreement taken as a whole do not contain any untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made
and when made, not misleading. The Company acknowledges and agrees
that no Purchaser makes or has made any representations or
warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section 3.2
hereof.
(z) No
Integrated Offering . Assuming the accuracy of the
Purchasers’ representations and warranties set forth in
Section 3.2, neither the Company, nor any of its Affiliates,
nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited
any offers to buy any security, under circumstances that would
cause this offering of the Securities to be integrated with prior
offerings by the Company for purposes of (i) the Securities
Act which would require the registration of any such securities
under the Securities Act, or (ii) any applicable shareholder
approval provisions of the Over-the-Counter Bulletin
Board.
16
(aa)
Solvency . Based on the consolidated financial condition of
the Company as of the Closing Date, after giving effect to the
receipt by the Company of the proceeds from the sale of the
Securities hereunder: (i) the fair saleable value of the
Company’s assets exceeds the amount that will be required to
be paid on or in respect of the Company’s existing debts and
other liabilities (including known contingent liabilities) as they
mature, (ii) the Company’s assets do not constitute
unreasonably small capital to carry on its business as now
conducted and as proposed to be conducted including its capital
needs taking into account the particular capital requirements of
the business conducted by the Company, and projected capital
requirements and capital availability thereof, and (iii) the
current cash flow of the Company, together with the proceeds the
Company would receive, were it to liquidate all of its assets,
after taking into account all anticipated uses of the cash, would
be sufficient to pay all amounts on or in respect of its
liabilities when such amounts are required to be paid. The Company
does not intend to incur debts beyond its ability to pay such debts
as they mature (taking into account the timing and amounts of cash
to be payable on or in respect of its debt). The Company has no
knowledge of any facts or circumstances which lead it to believe
that it will file for reorganization or liquidation under the
bankruptcy or reorganization laws of any jurisdiction within one
year from the Closing Date. Schedule 3.1(aa) sets forth
as of the date hereof all outstanding secured and unsecured
Indebtedness of the Company or any Subsidiary, or for which the
Company or any Subsidiary has commitments. For the purposes of this
Agreement, “ Indebtedness ” means (x) any
liabilities for borrowed money or amounts owed in excess of $50,000
(other than trade accounts payable incurred in the ordinary course
of business), (y) all guaranties, endorsements and other
contingent obligations in respect of indebtedness of others,
whether or not the same are or should be reflected in the
Company’s balance sheet (or the notes thereto), except
guaranties by endorsement of negotiable instruments for deposit or
collection or similar transactions in the ordinary course of
business; and (z) the present value of any lease payments in
excess of $50,000 due under leases required to be capitalized in
accordance with GAAP. Neither the Company nor any Subsidiary is in
default with respect to any Indebtedness.
(bb) Tax
Status . Except for matters that would not, individually or in
the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and each Subsidiary has filed
all necessary federal, state and foreign income and franchise tax
returns and has paid or accrued all taxes shown as due thereon, and
the Company has no knowledge of a tax deficienc
|